Loading...
XSHE002476
Market cap331mUSD
Jan 03, Last price  
3.97CNY
1D
-5.02%
1Q
-3.64%
Jan 2017
-61.96%
IPO
-27.61%
Name

Shandong Polymer Biochemicals Co Ltd

Chart & Performance

D1W1MN
XSHE:002476 chart
P/E
464.26
P/S
6.27
EPS
0.01
Div Yield, %
0.00%
Shrs. gr., 5y
-0.11%
Rev. gr., 5y
-2.95%
Revenues
387m
-34.60%
447,386,876542,753,724419,456,629515,409,798542,851,943581,184,378684,982,845667,606,686741,646,821898,010,140409,828,476449,890,702416,892,274447,314,622657,160,020592,284,770387,338,189
Net income
5m
-82.38%
25,787,54134,681,98542,815,37156,813,20267,803,33651,248,66146,932,20547,909,79024,138,43014,829,6718,270,361091,245,92613,182,60817,948,10929,702,7805,233,314
CFO
121m
18,855,46817,256,25881,795,64700169,829,43071,921,6150122,179,911145,106,40287,943,47352,747,62250,563,54932,516,43000120,964,050
Dividend
Jun 13, 20240.01 CNY/sh
Earnings
May 22, 2025

Profile

Shandong Polymer Biochemicals Co., Ltd., together with its subsidiaries, produces and sells oilfield chemicals in China and internationally. The company offers monomers, surfactants, and polymers. It is also involved in oil and gas engineering technology services; oil and gas exploration and development; and environmental water treatment businesses. The company was founded in 1996 and is based in Dongying, China.
URL
http://www.slcapam.com/
IPO date
Sep 15, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
387,338
-34.60%
592,285
-9.87%
Cost of revenue
366,559
522,267
Unusual Expense (Income)
NOPBT
20,779
70,018
NOPBT Margin
5.36%
11.82%
Operating Taxes
5,403
1,445
Tax Rate
26.00%
2.06%
NOPAT
15,376
68,573
Net income
5,233
-82.38%
29,703
65.49%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
21,880
11,381
Long-term debt
1,381
Deferred revenue
1,249
1,277
Other long-term liabilities
(342)
Net debt
(323,335)
(372,271)
Cash flow
Cash from operating activities
120,964
CAPEX
(6,967)
Cash from investing activities
(106,936)
Cash from financing activities
9,214
7,317
FCF
50,652
(6,628)
Balance
Cash
267,084
305,577
Long term investments
78,131
79,457
Excess cash
325,848
355,419
Stockholders' equity
647,650
694,624
Invested Capital
574,338
523,259
ROIC
2.80%
13.91%
ROCE
2.31%
7.97%
EV
Common stock shares outstanding
608,525
612,000
Price
6.42
18.45%
5.42
20.71%
Market cap
3,906,730
17.78%
3,317,040
20.71%
EV
3,583,395
2,944,769
EBITDA
45,431
104,903
EV/EBITDA
78.88
28.07
Interest
649
482
Interest/NOPBT
3.12%
0.69%